{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:07:17Z","timestamp":1791173237456,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["#5 U54 AI057158"],"award-info":[{"award-number":["#5 U54 AI057158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI13013"],"award-info":[{"award-number":["AI13013"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1 R21 AI082331-01"],"award-info":[{"award-number":["1 R21 AI082331-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology","award":["2012-0003632"],"award-info":[{"award-number":["2012-0003632"]}]},{"name":"the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea","award":["1020120"],"award-info":[{"award-number":["1020120"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.vaccine.2012.08.051","type":"journal-article","created":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T12:00:55Z","timestamp":1346500855000},"page":"6359-6367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205\/CD205 receptor"],"prefix":"10.1016","volume":"30","author":[{"given":"Yoonkyung","family":"Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud M.","family":"Didierlaurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongho","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyein","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford S.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph M.","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (49)","key":"10.1016\/j.vaccine.2012.08.051_bib0005","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1073\/pnas.0506840102","article-title":"Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity","volume":"102","author":"Lathem","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.08.051_bib0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/IAI.00403-06","article-title":"Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice","volume":"75","author":"Bubeck","year":"2007","journal-title":"Infect Immun"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2012.08.051_bib0015","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.vaccine.2005.11.047","article-title":"Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague","volume":"24","author":"Reed","year":"2006","journal-title":"Vaccine"},{"issue":"August (28)","key":"10.1016\/j.vaccine.2012.08.051_bib0020","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/S0264-410X(00)00128-6","article-title":"Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy","volume":"18","author":"Eyles","year":"2000","journal-title":"Vaccine"},{"issue":"April (21)","key":"10.1016\/j.vaccine.2012.08.051_bib0025","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0264-410X(00)00019-0","article-title":"Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses","volume":"18","author":"Baca-Estrada","year":"2000","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2012.08.051_bib0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(97)00249-1","article-title":"Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2012.08.051_bib0035","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","article-title":"Intranasal Protollin\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection","volume":"24","author":"Jones","year":"2006","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.08.051_bib0040","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.08.051_bib0045","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/IAI.74.5.3068-3070.2006","article-title":"Administration of antibody to the lung protects mice against pneumonic plague","volume":"74","author":"Hill","year":"2006","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.08.051_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/iai.61.1.23-31.1993","article-title":"Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha","volume":"61","author":"Nakajima","year":"1993","journal-title":"Infect Immun"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.08.051_bib0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2004.06.009","article-title":"Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague","volume":"37","author":"Elvin","year":"2004","journal-title":"Microb Pathog"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.08.051_bib0060","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.08.051_bib0065","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection","volume":"74","author":"Parent","year":"2006","journal-title":"Infect Immun"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2012.08.051_bib0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vaccine.2010.08.099","article-title":"TNFalpha and IFNgamma contribute to F1\/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague","volume":"29","author":"Lin","year":"2010","journal-title":"Vaccine"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2012.08.051_bib0075","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4049\/jimmunol.1003303","article-title":"IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection","volume":"186","author":"Lin","year":"2011","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.08.051_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/eji.200737799","article-title":"Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205\/CD205-positive mouse dendritic cells","volume":"38","author":"Do","year":"2008","journal-title":"Eur J Immunol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.08.051_bib0085","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/eji.201040511","article-title":"Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague","volume":"40","author":"Do","year":"2010","journal-title":"Eur J Immunol"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2012.08.051_bib0090","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.08.051_bib0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.20070891","article-title":"Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection","volume":"205","author":"Didierlaurent","year":"2008","journal-title":"J Exp Med"},{"issue":"July (11\u201312)","key":"10.1016\/j.vaccine.2012.08.051_bib0100","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.08.051_bib0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis \u2013 etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"May (17)","key":"10.1016\/j.vaccine.2012.08.051_bib0110","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.08.051_bib0115","unstructured":"Pitt ML. Animal models and correlates of protection for Plague Vaccines Workshop, Gaithersburg, MD. http:\/\/wwwfdagov\/cber\/minutes\/workshop-minhtm [13\u201314 October 2004]."},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.08.051_bib0120","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr3135","article-title":"Targeting of the non-mutated tumor antigen HER2\/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice","volume":"14","author":"Wang","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.08.051_bib0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/57.3.599","article-title":"A phase I-II trial of multiple-dose polyriboinosic\u2013polyribocytidylic acid in patieonts with leukemia or solid tumors","volume":"57","author":"Robinson","year":"1976","journal-title":"J Natl Cancer Inst"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.08.051_bib0130","doi-asserted-by":"crossref","first-page":"e1000373","DOI":"10.1371\/journal.ppat.1000373","article-title":"Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques","volume":"5","author":"Stahl-Hennig","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2012.08.051_bib0135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.immunol.24.021605.090650","article-title":"Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo","volume":"24","author":"Lefrancois","year":"2006","journal-title":"Annu Rev Immunol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2012.08.051_bib0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.20011558","article-title":"Differential T cell function and fate in lymph node and nonlymphoid tissues","volume":"195","author":"Harris","year":"2002","journal-title":"J Exp Med"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2012.08.051_bib0145","first-page":"107","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12012443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12012443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:18:54Z","timestamp":1759400334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12012443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":29,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0264410X12012443"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205\/CD205 receptor","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}